Literature DB >> 20546339

Cumulative alterations of p27-related cell-cycle regulators in the development of endometriosis-associated ovarian clear cell adenocarcinoma.

Sohei Yamamoto1, Hitoshi Tsuda, Kosuke Miyai, Masashi Takano, Seiichi Tamai, Osamu Matsubara.   

Abstract

AIMS: To identify the key cell-cycle dysregulations in the development of endometriosis-associated ovarian clear cell adenocarcinoma (CCA). METHODS AND
RESULTS: Expression of p27(Kip1)-interacting cell-cycle regulators, such as p27(Kip1) itself, Skp2, cyclin-dependent kinase subunit 1 (Cks1), cyclin A and cyclin E, and Ki67 labelling index (LI), were analysed by immunohistochemistry in 23 CCAs with 36 endometriotic or atypical endometriotic lesions adjacent to CCA from a cohort of 23 patients, and in 31 cases of solitary endometriosis. The cell-cycle regulators examined were overexpressed (Skp2, Cks1, cyclin A and cyclin E; P < 0.01, each) or down-regulated (p27(Kip1), P = 0.044) significantly more frequently in the CCAs than in the adjacent endometriosis. The frequency of Skp2 overexpression was significantly higher in atypical endometriosis than in endometriosis, and the frequency of Skp2 and cyclin A overexpression was significantly higher in CCA than in atypical endometriosis (P < 0.01, each). Mean Ki67 LI increased from endometriosis (8.4%) through atypical endometriosis (21.4%) to CCA (46.9%), with statistical significance between each component (P < 0.01, each). The frequency of cell-cycle regulator expression and mean Ki67 LIs were not significantly different between solitary endometriosis and endometriosis adjacent to CCA.
CONCLUSIONS: Alteration of the p27(Kip1)-interacting cell-cycle regulators appeared strongly involved in the progression of endometriosis-associated ovarian clear cell carcinogenesis through increasing cell proliferative activity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20546339     DOI: 10.1111/j.1365-2559.2010.03551.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  9 in total

1.  PIK3CA mutations and loss of ARID1A protein expression are early events in the development of cystic ovarian clear cell adenocarcinoma.

Authors:  Sohei Yamamoto; Hitoshi Tsuda; Masashi Takano; Seiichi Tamai; Osamu Matsubara
Journal:  Virchows Arch       Date:  2011-11-26       Impact factor: 4.064

2.  Aberrant expression of p27(Kip1)-interacting cell-cycle regulatory proteins in ovarian clear cell carcinomas and their precursors with special consideration of two distinct multistage clear cell carcinogenetic pathways.

Authors:  Sohei Yamamoto; Hitoshi Tsuda; Kosuke Miyai; Masashi Takano; Seiichi Tamai; Osamu Matsubara
Journal:  Virchows Arch       Date:  2009-10-24       Impact factor: 4.064

3.  Small cell ovarian carcinoma: genomic stability and responsiveness to therapeutics.

Authors:  Lisa F Gamwell; Karen Gambaro; Maria Merziotis; Colleen Crane; Suzanna L Arcand; Valerie Bourada; Christopher Davis; Jeremy A Squire; David G Huntsman; Patricia N Tonin; Barbara C Vanderhyden
Journal:  Orphanet J Rare Dis       Date:  2013-02-21       Impact factor: 4.123

4.  Cks1: Structure, Emerging Roles and Implications in Multiple Cancers.

Authors:  Vinayak Khattar; Jaideep V Thottassery
Journal:  J Cancer Ther       Date:  2013-10-01

5.  Cks overexpression enhances chemotherapeutic efficacy by overriding DNA damage checkpoints.

Authors:  S V del Rincón; M Widschwendter; D Sun; S Ekholm-Reed; J Tat; L K Teixeira; Z Ellederova; E Grolieres; S I Reed; C Spruck
Journal:  Oncogene       Date:  2014-05-26       Impact factor: 9.867

6.  Prognostic importance of atypical endometriosis with architectural hyperplasia versus cytologic atypia in endometriosis-associated ovarian cancer.

Authors:  Isabel Ñiguez Sevilla; Francisco Machado Linde; Maria Del Pilar Marín Sánchez; Julián Jesús Arense; Amparo Torroba; Anibal Nieto Díaz; Maria Luisa Sánchez Ferrer
Journal:  J Gynecol Oncol       Date:  2019-03-04       Impact factor: 4.401

7.  The Clinical Significance and Potential Molecular Mechanism of Upregulated CDC28 Protein Kinase Regulatory Subunit 1B in Osteosarcoma.

Authors:  Chaohua Mo; Le Xie; Chang Chen; Jie Ma; Yingxin Huang; Yanxing Wu; Yuanyuan Xu; Huizhi Peng; Zengwei Chen; Rongjun Mao
Journal:  J Oncol       Date:  2021-12-10       Impact factor: 4.375

Review 8.  A Systematic Review of Atypical Endometriosis-Associated Biomarkers.

Authors:  Ludovica Bartiromo; Matteo Schimberni; Roberta Villanacci; Giorgia Mangili; Stefano Ferrari; Jessica Ottolina; Noemi Salmeri; Carolina Dolci; Iacopo Tandoi; Massimo Candiani
Journal:  Int J Mol Sci       Date:  2022-04-17       Impact factor: 6.208

9.  miR‑508‑3p suppresses the development of ovarian carcinoma by targeting CCNA2 and MMP7.

Authors:  Fei Guo; Kai Zhang; Meiyue Li; Lei Cui; Guoyan Liu; Ye Yan; Wenyan Tian; Fei Teng; Yanfang Zhang; Chao Gao; Jinping Gao; Yingmei Wang; Fengxia Xue
Journal:  Int J Oncol       Date:  2020-04-27       Impact factor: 5.650

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.